BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15243841)

  • 1. Mammography screening in Switzerland: limited evidence from limited data.
    Zwahlen M; Bopp M; Probst-Hensch NM
    Swiss Med Wkly; 2004 May; 134(21-22):295-306. PubMed ID: 15243841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
    Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
    BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of organised versus opportunistic mammography screening.
    Bulliard JL; Ducros C; Jemelin C; Arzel B; Fioretta G; Levi F
    Ann Oncol; 2009 Jul; 20(7):1199-202. PubMed ID: 19282467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
    de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
    Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of breast cancer screening measures among immigrant and Swiss women in Switzerland.
    Fontana M; Bischoff A
    Swiss Med Wkly; 2008 Dec; 138(49-50):752-8. PubMed ID: 19130329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Breast cancer prevention behaviour: a perspective of women from three language regions of Switzerland].
    Glaus A; Fäh B; Hornung R; Senn H; Stiefel F
    Pflege; 2004 Dec; 17(6):385-94. PubMed ID: 15648588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of an organised programme and social inequalities in mammography screening: A 22-year population-based study in Geneva, Switzerland.
    Sandoval JL; Theler JM; Cullati S; Bouchardy C; Manor O; Gaspoz JM; Guessous I
    Prev Med; 2017 Oct; 103():49-55. PubMed ID: 28778819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between opportunistic and organised breast cancer mammography screening in the Swiss canton of Fribourg.
    Peisl S; Zimmermann S; Camey B; Betticher D; Bouchardy C
    BMC Cancer; 2019 May; 19(1):469. PubMed ID: 31101028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organised population-based programmes and change in socioeconomic inequalities in mammography screening: A 1992-2012 nationwide quasi-experimental study.
    Cullati S; von Arx M; Courvoisier DS; Sandoval JL; Manor O; Burton-Jeangros C; Bouchardy C; Guessous I
    Prev Med; 2018 Nov; 116():19-26. PubMed ID: 30145347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should breast cancer survivors be excluded from, or invited to, organised mammography screening programmes?
    Bucchi L
    BMC Health Serv Res; 2011 Oct; 11():249. PubMed ID: 21970334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening mammographies in Switzerland: what makes female and male physicians prescribe them?
    Keller B; Stutz EZ; Tibblin M; Ackermann-Liebrich U; Faisst K; Probst-Hensch N
    Swiss Med Wkly; 2001 Jun; 131(21-22):311-9. PubMed ID: 11584693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the use of mammography for early breast cancer detection in Switzerland: Swiss Health Surveys 2007 and 2012.
    Fenner L; Kässner A; Berlin C; Egger M; Zwahlen M
    Swiss Med Wkly; 2018; 148():w14603. PubMed ID: 29756635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who gets screened, and where: a comparison of organised and opportunistic mammography screening in Geneva, Switzerland.
    Chamot E; Charvet AI; Perneger TV
    Eur J Cancer; 2007 Feb; 43(3):576-84. PubMed ID: 17223542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health technology assessment of three screening methods in Switzerland.
    Faisst K; Schilling J; Koch P
    Int J Technol Assess Health Care; 2001; 17(3):389-99. PubMed ID: 11495382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain).
    Borràs JM; Guillen M; Sánchez V; Juncà S; Vicente R
    Eur J Cancer Prev; 1999 Oct; 8(5):427-34. PubMed ID: 10548398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
    Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
    Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How effective are breast cancer screening programmes by mammography? Review of the current evidence.
    Schopper D; de Wolf C
    Eur J Cancer; 2009 Jul; 45(11):1916-23. PubMed ID: 19398327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misconceptions about efficacy of mammography screening: a public health dilemma.
    Chamot E; Perneger TV
    J Epidemiol Community Health; 2001 Nov; 55(11):799-803. PubMed ID: 11604435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attendance in the second phase (2004-2005) of the Hungarian organized breast cancer screening program].
    Boncz I; Sebestyén A; Döbrossy L; Péntek Z; Kovács A; Budai A; Kövi R; Ember I
    Orv Hetil; 2008 Aug; 149(32):1491-8. PubMed ID: 18672438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes.
    Törnberg S; Carstensen J; Hakulinen T; Lenner P; Hatschek T; Lundgren B
    J Med Screen; 1994 Jul; 1(3):184-7. PubMed ID: 8790514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.